abcsg.research Publications 2003-2011

The benefit of adjuvant sequencing of tamoxifen and anastrozole over tamoxifen alone is confined in women with low proliferating endocrine-responsive breast cancer: Results from 1,587 centrally reviewed Ki67-labelling determinations in the Austrian Breast and Colorectal Cancer Study Group Trial 8

Bago-Horvath Z, Rudas M, Dubsky P, Jakesz R, Singer C, Dietze O, Greil R, Jelen A, Böhm G, Jasarevic Z, Haid A, Gruber C, Pöstlberger S, Filipits M, Gnant M.

Clin Cancer Res 17, 7828-7834, 2011.


A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors

Filipits M, Rudas M, Jakesz R, Dubsky P, Fitzal F, Singer CF, Dietze O, Greil R, Jelen A, Sevelda P, Freibauer C, Müller V, Jänicke F, Schmidt M, Kölbl H, Rody A, Kaufmann M, Schroth W, Schwab M, Brauch H, Fritz P, Weber KE, Feder IS, Hennig G, Kronenwett R, Gehrmann M, Gnant M.

Clin Cancer Res 17, 6012-6020, 2011.


Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy

Filipits M, Rudas M, Heinzl H, Jakesz R, Kubista E, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Nader A, Stierer M, Gnant MF, for the Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res 15, 5888-5894, 2009.


Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy

Rudas M, Lehnert M, Huynh A, Jakesz R, Singer C, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Grill R, Stierer M, Gnant MF, Filipits M, for the Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res 14, 1767-1774, 2008.


Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group

Filipits M, Pohl G, Rudas M, Dietze O, Lax S, Grill R, Pirker R, Zielinski CC, Hausmaninger H, Kubista E, Samonigg H, Jakesz R.

J Clin Oncol 23, 1161-1168, 2005.


High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin

Pohl G, Rudas M, Dietze O, Lax S, Markis E, Pirker R, Zielinski CC, Hausmaninger H, Kubista E, Samonigg H, Jakesz R, Filipits M.

J Clin Oncol 21, 3594-3600, 2003.